by Jerome Windsor | Nov 4, 2021 | Press Releases
– Partnership leverages Scipher Medicine’s proprietary patient clinico-genomic data – In silico patient models enable pharmaceutical companies to understand what disease treatments work for which patients and why Somerville, Mass., and Waltham,...
by Jerome Windsor | Oct 4, 2021 | Press Releases
Collaboration with Memorial Sloan Kettering Cancer Center’s Innovation Hub aims to answer key questions in prostate cancer patient care and accelerate discovery and development of new treatments Somerville, Mass.– October 5, 2021– GNS Healthcare (GNS), an artificial...
by Zena Sfeir | May 25, 2021 | Press Releases
Somerville, Mass., May 25, 2021: GNS Healthcare, an artificial intelligence company creating in silico patients that simulate drug treatment at the individual patient level, today announced plans to develop and launch Gemini — The in silico Patient™ for Prostate...
by gnsadmin | Mar 16, 2021 | Press Releases
Somerville, MA: GNS Healthcare, an AI company creating in silico patients to simulate disease progression and drug treatment at the individual patient level, is pleased to announce that accomplished finance executive Alan Kilyk has joined the company’s leadership team...
by Zena Sfeir | Jan 18, 2021 | Press Releases
Partnership enables enhanced capability to discover new targets and prognostic markers Somerville, MA: GNS Healthcare, the leading AI-driven precision medicine company, today announced a partnership with QIAGEN, the leading global provider of Sample to Insight...
by Simona Gilman | Jul 21, 2020 | Press Releases
AI-driven in silico patients used to accurately identify types of immune responses in head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC). CAMBRIDGE, Mass.– [July 21, 2020] – GNS Healthcare (GNS), a leading AI and simulation company,...
